Accelerate Diagnostics, Inc. , an in vitro diagnostics company, provides solutions for the diagnosis of serious infections in the United States, Europe, and the Middle East.
Accelerate Diagnostics stock last closed at $0.57, up 6.79% from the previous day, and has decreased 36.19% in one year. It has underperformed other stocks in the Medical Devices industry by 0.19 percentage points. Accelerate Diagnostics stock is currently +15.51% from its 52-week low of $0.49, and -72.92% from its 52-week high of $2.09.
There are currently 25.21M shares of AXDX outstanding. The market value of AXDX is $14.27M. In the past 24 hours, 29,244 AXDX shares were traded.
How to Buy Accelerate Diagnostics Stock
Not sure how to invest in Accelerate Diagnostics stock? Here's how.
Decide where to buy Accelerate Diagnostics stock: You need to pick a stock brokerage, but don't worry - we've sifted through dozens of online stock brokerages and apps to help you determine where to buy Accelerate Diagnostics stock.
Open your brokerage account: Sign up for 0% commission trading with the highest-rated brokerage we've identified.
Deposit money your investment account: Choose your payment method and add your information.
Research Accelerate Diagnostics stock: The Accelerate Diagnostics ticker symbol is AXDX. Is Accelerate Diagnostics stock a good investment? Should you buy shares of AXDX? How do AXDX's underlying business fundamentals look? Do top analysts think Accelerate Diagnostics is a good buy? Why has AXDX's stock price moved recently? (Hint: Our stock analysis website can help you figure out if AXDX is a good stock to buy).
Make your AXDX purchase: Decide if you will purchase AXDX shares at the current market price or use a limit order to purchase AXDX shares at a given price.
Monitor your AXDX position: Create a watchlist to important notifications about your position in Accelerate Diagnostics shares.
Step 1: Decide where to buy Accelerate Diagnostics stock
You need an online brokerage account in order to access the NASDAQ market and buy AXDX stock.
A brokerage account enables you to buy and sell a variety of financial instruments, such as stocks, bonds, mutual funds, and ETFs.
Our favorite brokerage: eToro
In our opinion, eToro is the best place to buy stocks. Here's why:
Invest in stocks with zero commissions: Invest without commissions.
Buy fractional shares: Even if you don't have the money to buy a full share, you can still buy the stock.
Access to world financial markets: From Technology to Real Estate, New York to London (for US users, only US stocks are available) — you can fill your portfolio with stocks from the world's top stock exchanges.
Social investing: eToro offers a community with more than 20 million users around the world. Talk to, learn from, and copy the crypto trades of other investors.
Security: eToro is a regulated and licensed fintech leader.
Buy other assets: Such as ETFs and cryptos.
Get $10 towards your purchase of stock by signing up for an account with eToro today. This offer is only for US users.
eToro securities trading is offered by eToro USA Securities, Inc. (“the BD”), member of FINRA and SIPC. Cryptocurrency is offered by eToro USA LLC (“the MSB”) (NMLS: 1769299) and is not FDIC or SIPC insured. Investing involves risk, and content is provided for educational purposes only, does not imply a recommendation, and is not a guarantee of future performance. https://www.wallstreetzen.com is not an affiliate and may be compensated if you access certain products or services offered by the MSB and/or the BD.
Step 2: Open your brokerage account
Now that you've picked the right brokerage, the next step is to fill out some personal info so you can invest in AXDX today.
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
Step 4: Research Accelerate Diagnostics stock
After you have selected the best place to buy Accelerate Diagnostics stock, it's crucial to research their stock prior to buying, so you actually wrap your head around the risk as well as the upside.
Accelerate Diagnostics shares data
AXDX Price
$0.57
1w %
4.81%
1y %
-36.19%
5y %
-99.41%
P/E
-0.26x
P/B
-0.25x
P/S
1.13x
PEG
N/A
Revenue
$11.70M
Earnings
-$50.05M
Fore. Rev. Growth
N/A
Fore. Earn. Growth
N/A
Market Cap
$14.27M
Next Earnings
May 6, 2025
Next Dividend
N/A
Accelerate Diagnostics Due Diligence Checks
WallStreetZen was designed to help everyday investors do more accurate fundamental analysis in minutes instead of hours.
Last year, AXDX revenue was $11.70M. Over the last 5 year, AXDX's revenue has grown by 4.7% per year. This was slower than the Medical Devices industry average of 9.81%.
No, Accelerate Diagnostics doesn't provide an income stream by paying out dividends.
AXDX Social Trading Data
One of the primary reasons eToro is our top-rated brokerage is because of its social trading community.
Click below to learn what other traders have to say.
Step 5: Make your AXDX purchase
You have two main options:
Market order: A market order is an order to buy or sell a security at the best price on the market. Market orders are generally the easiest way to buy.
Limit order: A limit order lets you buy or sell a security at a specific price (or better). If you want to be certain you're buying or selling at an exact dollar amount, use a limit order.
Press the Open Trade button and your broker will execute the order.
If you require additional info about buying stocks on eToro, click the how to video below:
How much does it cost to buy one Accelerate Diagnostics share?
As of Apr 22, 2025, it costs $0.57 to buy one share of Accelerate Diagnostics stock.
Remember, eToro's fractional share buying allows you to buy partial shares of stocks and ETFs. Even if you only have $0.28, you can buy 0.5 shares of AXDX.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.